Cargando…

Use and perceived benefits and barriers of QSAR models for REACH: findings from a questionnaire to stakeholders

The ORCHESTRA online questionnaire on “benefits and barriers to the use of QSAR methods” addressed the academic, consultant, regulatory and industry communities potentially interested by QSAR methods in the context of REACH. Replies from more than 60 stakeholders produced some insights on the actual...

Descripción completa

Detalles Bibliográficos
Autores principales: Mays, Claire, Benfenati, Emilio, Pardoe, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771413/
https://www.ncbi.nlm.nih.gov/pubmed/23244245
http://dx.doi.org/10.1186/1752-153X-6-159
_version_ 1782284192974897152
author Mays, Claire
Benfenati, Emilio
Pardoe, Simon
author_facet Mays, Claire
Benfenati, Emilio
Pardoe, Simon
author_sort Mays, Claire
collection PubMed
description The ORCHESTRA online questionnaire on “benefits and barriers to the use of QSAR methods” addressed the academic, consultant, regulatory and industry communities potentially interested by QSAR methods in the context of REACH. Replies from more than 60 stakeholders produced some insights on the actual application of QSAR methods, and how to improve their use. Respondents state in majority that they have used QSAR methods. All have some future plans to test or use QSAR methods in accordance with their stakeholder role. The stakeholder respondents cited a total of 28 models, methods or software that they have actually applied. The three most frequently cited suites, used moreover by all the stakeholder categories, are the OECD Toolbox, EPISuite and CAESAR; all are free tools. Results suggest that stereotyped assumptions about the barriers to application of QSAR may be incorrect. Economic costs (including potential delays) are not found to be a major barrier. And only one respondent “prefers” traditional, well-known and accepted toxicological assessment methods. Information and guidance may be the keys to reinforcing use of QSAR models. Regulators appear most interested in obtaining clear explanation of the basis of the models, to provide a solid basis for decisions. Scientists appear most interested in the exploration of the scientific capabilities of the QSAR approach. Industry shows interest in obtaining reassurance that appropriate uses of QSAR will be accepted by regulators.
format Online
Article
Text
id pubmed-3771413
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37714132013-09-13 Use and perceived benefits and barriers of QSAR models for REACH: findings from a questionnaire to stakeholders Mays, Claire Benfenati, Emilio Pardoe, Simon Chem Cent J Short Report The ORCHESTRA online questionnaire on “benefits and barriers to the use of QSAR methods” addressed the academic, consultant, regulatory and industry communities potentially interested by QSAR methods in the context of REACH. Replies from more than 60 stakeholders produced some insights on the actual application of QSAR methods, and how to improve their use. Respondents state in majority that they have used QSAR methods. All have some future plans to test or use QSAR methods in accordance with their stakeholder role. The stakeholder respondents cited a total of 28 models, methods or software that they have actually applied. The three most frequently cited suites, used moreover by all the stakeholder categories, are the OECD Toolbox, EPISuite and CAESAR; all are free tools. Results suggest that stereotyped assumptions about the barriers to application of QSAR may be incorrect. Economic costs (including potential delays) are not found to be a major barrier. And only one respondent “prefers” traditional, well-known and accepted toxicological assessment methods. Information and guidance may be the keys to reinforcing use of QSAR models. Regulators appear most interested in obtaining clear explanation of the basis of the models, to provide a solid basis for decisions. Scientists appear most interested in the exploration of the scientific capabilities of the QSAR approach. Industry shows interest in obtaining reassurance that appropriate uses of QSAR will be accepted by regulators. BioMed Central 2012-12-18 /pmc/articles/PMC3771413/ /pubmed/23244245 http://dx.doi.org/10.1186/1752-153X-6-159 Text en Copyright © 2012 Mays et al.; licensee Chemistry Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Report
Mays, Claire
Benfenati, Emilio
Pardoe, Simon
Use and perceived benefits and barriers of QSAR models for REACH: findings from a questionnaire to stakeholders
title Use and perceived benefits and barriers of QSAR models for REACH: findings from a questionnaire to stakeholders
title_full Use and perceived benefits and barriers of QSAR models for REACH: findings from a questionnaire to stakeholders
title_fullStr Use and perceived benefits and barriers of QSAR models for REACH: findings from a questionnaire to stakeholders
title_full_unstemmed Use and perceived benefits and barriers of QSAR models for REACH: findings from a questionnaire to stakeholders
title_short Use and perceived benefits and barriers of QSAR models for REACH: findings from a questionnaire to stakeholders
title_sort use and perceived benefits and barriers of qsar models for reach: findings from a questionnaire to stakeholders
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771413/
https://www.ncbi.nlm.nih.gov/pubmed/23244245
http://dx.doi.org/10.1186/1752-153X-6-159
work_keys_str_mv AT maysclaire useandperceivedbenefitsandbarriersofqsarmodelsforreachfindingsfromaquestionnairetostakeholders
AT benfenatiemilio useandperceivedbenefitsandbarriersofqsarmodelsforreachfindingsfromaquestionnairetostakeholders
AT pardoesimon useandperceivedbenefitsandbarriersofqsarmodelsforreachfindingsfromaquestionnairetostakeholders